EU Panel Backs Drugs for Hypoglycemia, Osteoporosis
After an initial no, CHMP backs romosozumab for severe osteoporosis with high fracture risk; Baqsimi is the first nasally administered treatment for severe hypoglycemia. International Approvals …read more